Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Hawkeye Digital, Inc.HWKE · Entity 6130 | Director | May 04, 2026 | May 04, 2026 |
| cbdMD, Inc.YCBD · Entity 8230 | Director | March 12, 2021 | October 05, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Hawkeye Digital, Inc.
Report date May 04, 2026 · Filed May 04, 2026
This filing explicitly reported no securities owned.
cbdMD, Inc.
Report date March 12, 2021 · Filed October 05, 2021 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 7,000 |
Reported balance
After 2021-03-12 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2021-03-12 · Grant · Acquired 7,000 · Balance 7,000 F1: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest as follows: 2,000 vested on March 12, 2021 and the remaining 5,000 vest quarterly in equal increments over a one year period from the grant date with the last vesting being on March 12, 2022, subject to continued service as a director of the Issuer on each applicable vesting date. Shares of common stock will be delivered to the Reporting Person upon the vesting of the restricted stock units. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 12, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest as follows: 2,000 vested on March 12, 2021 and the remaining 5,000 vest quarterly in equal increments over a one year period from the grant date with the last vesting being on March 12, 2022, subject to continued service as a director of the Issuer on each applicable vesting date. Shares of common stock will be delivered to the Reporting Person upon the vesting of the restricted stock units. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 12, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 12, 2021 Filed Mar 16, 2021 15:03 UTC | cbdMD, Inc. YCBD · Entity 8230 | Grantstock option · Derivative | 30,000 | $0.00 Strike: $4.40 | $0.00 |
DisclosureSEC source: 0001654954-21-002856 · section16.xml · derivative · entry 6 Farar Sim · CIK 0001851461 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: common stock · 30,000 shares Expires 2026-03-11 Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 15:03 UTC | cbdMD, Inc. YCBD · Entity 8230 | Grantrestricted stock award · Derivative | 1,250 | $4.40 Strike: $0.00 | $5,500.00 |
DisclosureSEC source: 0001654954-21-002856 · section16.xml · derivative · entry 5 Farar Sim · CIK 0001851461 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Underlying: common stock · 1,250 shares Expires 2022-03-12 Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 15:03 UTC | cbdMD, Inc. YCBD · Entity 8230 | Grantrestricted stock award · Derivative | 1,250 | $4.40 Strike: $0.00 | $5,500.00 |
DisclosureSEC source: 0001654954-21-002856 · section16.xml · derivative · entry 4 Farar Sim · CIK 0001851461 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Underlying: common stock · 1,250 shares Expires 2021-12-31 Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 15:03 UTC | cbdMD, Inc. YCBD · Entity 8230 | Grantrestricted stock award · Derivative | 1,250 | $4.40 Strike: $0.00 | $5,500.00 |
DisclosureSEC source: 0001654954-21-002856 · section16.xml · derivative · entry 3 Farar Sim · CIK 0001851461 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Underlying: common stock · 1,250 shares Expires 2021-09-30 Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 15:03 UTC | cbdMD, Inc. YCBD · Entity 8230 | Grantrestricted stock award · Derivative | 1,250 | $4.40 Strike: $0.00 | $5,500.00 |
DisclosureSEC source: 0001654954-21-002856 · section16.xml · derivative · entry 2 Farar Sim · CIK 0001851461 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250 Underlying: common stock · 1,250 shares Expires 2021-06-30 Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 15:03 UTC | cbdMD, Inc. YCBD · Entity 8230 | Grantrestricted stock award · Derivative | 2,000 | $4.40 Strike: $0.00 | $8,800.00 |
DisclosureSEC source: 0001654954-21-002856 · section16.xml · derivative · entry 1 Farar Sim · CIK 0001851461 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: common stock · 2,000 shares Expires 2021-03-12 Read SEC document |
| March 12, 2021 Filed Oct 5, 2021 17:42 UTC Amendment | cbdMD, Inc. YCBD · Entity 8230 | GrantCommon stock | 7,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-010808 · section16.xml · nonDerivative · entry 1 Farar Sim · CIK 0001851461 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest as follows: 2,000 vested on March 12, 2021 and the remaining 5,000 vest quarterly in equal increments over a one year period from the grant date with the last vesting being on March 12, 2022, subject to continued service as a director of the Issuer on each applicable vesting date. Shares of common stock will be delivered to the Reporting Person upon the vesting of the restricted stock units. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 12, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.